Evidence map›Paper›PMID 39200908›Full record

ArticleJournal of clinical medicine2024

Mortality during the SARS-CoV-2 Pandemic: A Comparative Analysis between Lombardy in Italy and Israel.

Ronza Najjar-Debbiny, Alessandro Nobili, Pier Mannuccio Mannucci, Ofra Barnett-Griness, Walid Saliba, Yochai Adir, Alessia Antonella Galbussera, Mauro Tettamanti, Barbara D'Avanzo, Sergio Harari

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ronza Najjar-DebbinyInfection Control and Prevention Unit, Lady Davis Carmel Medical Center, Haifa 3436212, Israel.ORCID 0000-0001-7586-3714
Alessandro NobiliDepartment of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.ORCID 0000-0002-7813-0572
Pier Mannuccio MannucciDepart Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, 20122 Milan, Italy.ORCID 0000-0002-1915-3897
Ofra Barnett-GrinessDepartment of Community Medicine and Epidemiology, Lady Davis Carmel Medical Center, Haifa 3436212, Israel.
Walid SalibaRuth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3436212, Israel.
Yochai AdirRuth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3436212, Israel.
Alessia Antonella GalbusseraDepartment of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.ORCID 0000-0003-0163-1034
Mauro TettamantiDepartment of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.ORCID 0000-0001-7345-0887
Barbara D'AvanzoDepartment of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.
Sergio HarariDepartment of Clinical Sciences and Community Health, Università di Milano, 20123 Milan, Italy.ORCID 0000-0001-8629-7391

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

IsraelLombardymortalitySARS-CoV-2vaccine

Identifiers

PMID39200908
PMCPMC11355292

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.